These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1495700)

  • 1. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.
    Piper JM; Ray WA; Rosa FW
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):429-32. PubMed ID: 1495700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal anuria with maternal angiotensin-converting enzyme inhibition.
    Rosa FW; Bosco LA; Graham CF; Milstien JB; Dreis M; Creamer J
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):371-4. PubMed ID: 2761913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy.
    Bowen ME; Ray WA; Arbogast PG; Ding H; Cooper WO
    Am J Obstet Gynecol; 2008 Mar; 198(3):291.e1-5. PubMed ID: 18191803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.
    Chisholm CA; Chescheir NC; Kennedy M
    Am J Perinatol; 1997 Oct; 14(9):511-3. PubMed ID: 9394157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
    Schaefer C
    Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitor fetopathy.
    Hegde AU; Parekji S; Ali US; Mehta KP
    Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
    [No Abstract]   [Full Text] [Related]  

  • 10. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy.
    Hanssens M; Keirse MJ; Vankelecom F; Van Assche FA
    Obstet Gynecol; 1991 Jul; 78(1):128-35. PubMed ID: 2047053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.
    Tabacova S; Little R; Tsong Y; Vega A; Kimmel CA
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):633-46. PubMed ID: 14762979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of neonatal anuria.
    Prasad N; Gulati S; Jain M; Tewari P
    Indian Pediatr; 2003 Mar; 40(3):258-60. PubMed ID: 12657763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fetopathy associated with exposure to angiotensin converting enzyme inhibitors].
    Neves S; Santos R; Gomes C; Correia AJ
    Acta Med Port; 2010; 23(4):697-700. PubMed ID: 20687999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to drugs: angiotensin-converting enzyme inhibitors and pregnancy.
    Birbari AE
    J Med Liban; 1993; 41(2):99. PubMed ID: 8057352
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal use of metronidazole and birth defects: no association.
    Piper JM; Mitchel EF; Ray WA
    Obstet Gynecol; 1993 Sep; 82(3):348-52. PubMed ID: 8355932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient use of cardiovascular drugs during pregnancy.
    Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Dal Pan GJ; Scott PE; Platt R
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):240-7. PubMed ID: 18200619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
    Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies.
    Karthikeyan VJ; Ferner RE; Baghdadi S; Lane DA; Lip GY; Beevers DG
    J Hypertens; 2011 Feb; 29(2):396-9. PubMed ID: 21119533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.